Financhill
Sell
40

BEAM Quote, Financials, Valuation and Earnings

Last price:
$17.41
Seasonality move :
31.21%
Day range:
$17.37 - $18.75
52-week range:
$13.53 - $35.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
22.97x
P/B ratio:
1.56x
Volume:
2.4M
Avg. volume:
2.8M
1-year change:
-22.76%
Market cap:
$1.8B
Revenue:
$63.5M
EPS (TTM):
-$4.61

Earnings Data

Next earnings date for BEAM
Aug 06
2025
Most recent earnings per share
-$1.24
Missed by $0.07
(May 6/2025)
Consensus Estimate
-$1.17
(May 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BEAM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/06/2025 Q2 $13.7M -- -- -$1.10 --
05/06/2025 Q1 $14.7M $7.5M -$1.24 -$1.17 -$0.07
02/25/2025 Q4 $16.5M $30.1M -$1.09 -$1.22 $0.13
11/05/2024 Q3 $14.1M $14.3M -$1.17 -$1.18 $0.01
08/06/2024 Q2 $13M $11.8M -$1.11 -$1.12 $0.01
05/07/2024 Q1 $14.7M $7.4M -$1.21 -$1.39 $0.18
02/27/2024 Q4 $33.7M $316.2M $1.73 -$0.71 $2.44
11/08/2023 Q3 -- -- -$1.22 -$1.27 $0.05
08/08/2023 Q2 -- -- -$1.08 -$1.38 $0.30
05/10/2023 Q1 -- -- -$1.33 -$1.30 -$0.03
02/28/2023 Q4 -- -- -$0.54 -$1.34 $0.80
11/07/2022 Q3 -- -- -$1.56 -$1.09 -$0.47
08/09/2022 Q2 -- -- -$1.02 -$1.02 $0.00
05/09/2022 Q1 -- -- -$1.01 -$1.34 $0.33
02/28/2022 Q4 -- -- -$0.95 -$0.94 -$0.01
11/08/2021 Q3 -- -- -$0.42 -$0.72 $0.30
08/10/2021 Q2 -- -- -$1.23 -$0.74 -$0.49
05/11/2021 Q1 -- -- -$3.35 -$0.75 -$2.60
03/30/2021 Q4 -- -- -$1.88 -$0.68 -$1.20
11/10/2020 Q3 -- -- -$0.69 -$0.54 -$0.15
08/12/2020 Q2 -- -- -$0.69 -$0.51 -$0.18
05/12/2020 Q1 -- -- -$1.03 -$0.48 -$0.55
03/30/2020 Q4 -- -- -$0.69 -$0.49 -$0.20
09/30/2019 Q3 -- -- -$0.63 -- --
06/30/2019 Q2 -- -- -$0.60 -- --
03/31/2019 Q1 -- -- -$0.47 -- --
12/31/2018 Q4 -- -- -$0.75 -- --
09/30/2018 Q3 -- -- -$2.00 -- --

Beam Therapeutics Earnings Questions

  • How Much did Beam Therapeutics Generate in Revenue Last Quarter?

    Beam Therapeutics reported $7.5M worth of top line sales in its most recent quarter.

  • Did Beam Therapeutics Beat Earnings Last Quarter?

    Beam Therapeutics announced earnings per share of -$1.24 which represents a miss of analyst forecast a -$1.17 per share.

  • Is Beam Therapeutics Profitable?

    Beam Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Beam Therapeutics EPS Next Year?

    Beam Therapeutics's earnings are forecast to decrease from -$4.58 per share to -$4.68 per share next year representing a decrease of -0.85%.

  • When is Beam Therapeutics's Earnings Date?

    Beam Therapeutics's next earnings date is August 6, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Spotify a Millionaire-Maker Stock?
Is Spotify a Millionaire-Maker Stock?

Spotify (NYSE:SPOT) may seem like an expensive proposition trading closer…

What Is a Millionaire-Maker Stock?
What Is a Millionaire-Maker Stock?

From time to time, investors will run across the term…

5 Investors to Follow Other Than Warren Buffett
5 Investors to Follow Other Than Warren Buffett

There is no doubt that Warren Buffett is one of…

Stock Ideas

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
QDEL alert for May 10

QuidelOrtho [QDEL] is down 0.22% over the past day.

Buy
97
NGVC alert for May 10

Natural Grocers by Vitamin Cottage [NGVC] is up 30.26% over the past day.

Sell
38
ONTO alert for May 10

Onto Innovation [ONTO] is down 30.17% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock